VaxNewMO

Biotechnology company · Saint Louis, Missouri, United States

VaxNewMO is a biotechnology company headquartered in Saint Louis, Missouri, United States. It has received 9 US government small-business research awards (SBIR/STTR) from health agencies, $11 million in total, most recently in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

VaxNewMO at a glance

Typebiotechnology company

HeadquartersSaint Louis, Missouri, United States

Employees (self-reported, 2025)1

What does VaxNewMO do?

US government research funding

9 SBIR/STTR small-business research awards from US health agencies, $11.2 million in total (2017 to 2025). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Frequently asked questions about VaxNewMO

Where is VaxNewMO headquartered?

VaxNewMO is headquartered in Saint Louis, Missouri, United States.

What does VaxNewMO do?

VaxNewMO is a biotechnology company.

Similar companies

MediBeacon Inc.St. Louis, Missouri, United States
C2N Diagnostics, LLCSt. Louis, Missouri, United States
Pulse Therapeutics, Inc.St. Louis, Missouri, United States
Panome Bio Inc.St. Louis, Missouri, United States
Cardialen, Inc.St. Louis, Missouri, United States
Gateway Biotechnology, Inc.St. Louis, Missouri, United States
Confluence Life Sciences, Inc.St. Louis, Missouri, United States
BacterioScan, Inc.St. Louis, Missouri, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences